When managing complex chronic dermatologic diseases, efforts to incorporate alternative treatments can add efficacy, patient ...

The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...

Paxneury and Tuzulby should be granted Europe-wide marketing authorizations for treating attention-deficit hyperactivity, the ...

The European Medicines Agency (EMA) has given a positive recommendation for Rytelo ( imetelstat) for the treatment of adult ...

The different associations of standing hypertension and systolic orthostatic increases in BP with CVD raises concerns about ...

Oral doxycycline may be as effective as IV penicillin in treating ocular syphilis for some patients with the condition, a new ...

A case series showed that chimeric antigen receptor T-cell therapy targeting CD19 halted the progression of fibrotic organ ...

Results of the INSEMA trial indicated that it’s safe to omit axillary sentinel lymph node biopsy in patients with clinically ...

Incorporating NT-proBNP, a biomarker for heart failure, into traditional risk prediction models for AF may enhance early ...

Antimicrobial peptides have not typically lived up to their promise, especially when it comes to beating antibiotic ...

Use of general anesthesia for cesarean deliveries increased the risk for postpartum depression and suicidality, as per a new ...

Europe’s medicines regulator has backed a pediatric indication for Ofev to treat progressive fibrosing interstitial lung ...